Tiova Rotacap
Indicated to address chronic bronchospastic conditions to relieve breathing restriction and support steady pulmonary expansion.
- Category
- Respiratory Health
- Active ingredient
- Tiotropium
- Route
- Inhalation use
- Form
- Capsule
- Strengths
- 18mcg
Prescription and consultation requirements for Tiova Rotacap vary by destination and are determined by the fulfilment partner.
Tiova Rotacap details
- Alternative names
- tiotropium
- Therapeutic class
- Anticholinergic Bronchodilator
- Pharmacological class
- Muscarinic Antagonist
- Known off-label uses
- asthma
- Contraindications
- hypersensitivity to tiotropium; hypersensitivity to atropine
- Minor side effects
- dry mouth; throat irritation; cough
- Moderate side effects
- sinusitis; constipation; headache
- Dosage forms
- Capsule
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 30 minutes
- Duration
- 24 hours
- Storage instructions
- Store below 25°C. Do not freeze.
- Drug interactions
- Ipratropium; Anticholinergics
- Age restrictions
- Approved for adults.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; acute narrow-angle glaucoma, requires immediate medical attention
Patient summary
indicated to address chronic bronchospastic conditions to relieve breathing restriction and support steady pulmonary expansion.
Mechanism of action
Inhibits muscarinic M3 receptors in bronchial smooth muscles, blocking vagally mediated acetylcholine bronchoconstriction.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.